SCOTTSDALE, Ariz., March 03, 2017 -- TPI Composites, Inc. (“TPI”) (Nasdaq:TPIC), the largest U.S.-based independent manufacturer of composite wind blades, today announced that its management team will attend the following investor conferences:
38th Annual Raymond James Institutional Investors Conference
March 6, 2017
Orlando, Florida
29th Annual ROTH Conference
March 14, 2017
Dana Point, California
About TPI Composites, Inc.
TPI Composites, Inc. is the largest U.S.-based independent manufacturer of composite wind blades for the wind energy market. TPI delivers high-quality, cost-effective composite solutions through long term relationships with leading wind turbine manufacturers. TPI is headquartered in Scottsdale, Arizona and operates factories throughout the U.S., Mexico, China and Turkey.
Investor Contact: [email protected] 480-315-8742


Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 



